Jenner Biotherapies, Inc.

PROFILE Jenner Biotherapies (formerly Jenner Technologies), a development stage company, is working on drugs and drug delivery systems to treat various cancers and side effects related to chemotherapy. The company's research involves development of both cancer vaccines and macrophage activators, which prompt the immune system to attack tumors and also alleviate the side effects of chemotherapy. Jenner's lead product, ACT, stimulates macrophages to destroy cancer cells and is currently in late-stage clinical trials. Other products include vaccines for prostate, colorectal, lung, pancreatic, and ovarian cancer.  COMPETITION AVI BioPharma Inc. (AVII) CEL-SCI Corporation (CVM) Genzyme Molecular Oncology (GZMO)		FINANCIAL OVERVIEW 1997 Sales (mil.): 0.00 Employees: 10 Revenue per employee: $0.00  KEY PEOPLE • Hayden Leason     CEO • Hayden Leason     CFO  CONTACT INFO 541 Kenosha St. Walworth, WI 53184 US Phone: 262-275-8389 Fax: 262-275-8381 Online: Web Site

	Company Data   News, quotes & more

		Hoover's Company Capsule Copyright © 2001, Hoover's Inc. Austin, Texas. For changes and updates, contact Hoover's directly.